CraniUS’ Disruptive Innovation
CraniUS is developing the first medical device that enables chronic medicine delivery directly to the brain, powered by a novel wireless charging system.
CraniUS’ Disruptive Innovation
The first fully implantable, wireless medical device that enables chronic and direct delivery of medicine to the brain.
Meet our team
Forward-thinkers driving patient and user-focused innovation
By bringing diverse skills together, we advance the output and quality of CraniUS.
Dr. Chad Gordon
Co-Founder, Executive Chair, & CMO
Michael Maglin
CEO
Jack Kent
VP, Strategy & Operations
Celebrate Our Successes
The future of improved patient and user-focused outcomes
“When evaluating the MRI images from the devices tested by the company, the CraniUS NeuroPass device is on the way to achieving its goal of convection and that gadolinium was spreading within the white matter of the brain.”
Martin Pomper, M.D., Ph. D., Professor of Radiology at Johns Hopkins University
“What CraniUS has built, and now tested successfully, in their large animal study is without question a quantum leap forward for our field. It has the immense potential to be a major disruptor in terms of how we, as neurosurgeons, approach and treat brain disease moving forward.”
Henry Brem, MD
“I could not be any prouder of our talented team and the findings of this recent breakthrough study. Being able to show that our patented device is both safe and effective in achieving convection in large animals with similar brains to humans represents a tremendous culmination of hard work and determination by our team.”
Mike Maglin, CEO of CraniUS
